Table 3 Assessment and characteristics of the HZ-associated pain and quality of life scores at each study visit
Visit | ||||
|---|---|---|---|---|
Enrolment | 1 month | 3 months | 6 months | |
Number of patients who completed the visit | 413 | 390 | 353 | 368 |
Patients reporting pain at the respective visit | ||||
Number of patients | 370 | 193 | 73 | 34 |
Mean VAS score for patients reporting pain ± SD | 5.8 ± 2.4 | 4.4 ± 2.3 | 3.7 ± 2.0 | 3.7 ± 2.3 |
Main characteristics of HZ-associated pain (%) | ||||
Allodynia | 59.7 | 49.2 | 56.2 | 52.9 |
Itching | 74.3 | 27.5 | 21.9 | 17.7 |
Paresthesia | 58.9 | 49.7 | 52.1 | 38.2 |
Malaise | 20.8 | 14.0 | 13.7 | 8.8 |
Quality of life score (SF12) | ||||
Mean PCS-12 score ± SD | 39.2 ± 8.4 | 37.7 ± 8.3 | 40.1 ± 8.4 | 39.0 ± 9.3 |
Mean MCS-12 score ± SD | 41.6 ± 10.4 | 39.3 ± 10.4 | 39.6 ± 9.8 | 39.4 ± 10.6 |
Patients with a VAS score ≥3 at the respective visit | ||||
Number of patients | 308 | 175 | 71 | 50 |
Mean VAS score among these patients | 6.4 ± 1.9 | 5.2 ± 1.9 | 4.9 ± 1.8 | 5.4 ± 2.1 |